Abstract
The present study was aimed at evaluating the clinical efficacy of a combination of nimodipine and edaravone in the treatment of acute cerebral hemorrhage. A total of 180 patients diagnosed with acute cerebral hemorrhage and treated at the Shandong Jiyang Public Hospital were enrolled. The patients were divided into the control group and the research group with 90 patients in each group. Patients in the control group were treated with edaravone, while a combination of nimodipine and edaravone was administered to patients in the research group. Total therapeutic efficacy, neurologic impairment score, quality of life score, hematoma and edema volume were compared between both groups. Results obtained demonstrated that the total therapeutic efficacy of the research group was better than that of the control group (p<0.05). Patients’ hematoma and edema volume before and after treatment on comparison indicated that improvement in the research group after drug administration was significantly better than that of the control group (p<0.05). Moreover, there was a greater decrease in the neurologic impairment score of the research group than that of the control group (p<0.05). Application of a combination of nimodipine and edaravone in the treatment of acute cerebral hemorrhage could achieve greater clinical efficacy as well as significantly improve the therapeutic efficiency.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
